Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A-Armed Modified Ankara-Vaccinia Virus Vectored Vaccines in Nasopharyngeal Cancer

Background: The Epstein-Barr virus (EBV) is intricately linked to a range of human malignancies, with EBV latent membrane protein 2A (LMP2A) emerging as a potential target antigen for immunotherapeutic strategies in the treatment of nasopharyngeal carcinoma (NPC). Methods: The modified vaccinia viru...

Descripció completa

Dades bibliogràfiques

Autors principals:	Liying Sun, Chao Liu, Junping Peng
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-01-01
Col·lecció:	Pharmaceutics
Matèries:	Epstein-Barr virus latent membrane protein 2A modified vaccinia virus ankara nasopharyngeal cancer cytotoxic lymphocyte anti-tumor effect
Accés en línia:	https://www.mdpi.com/1999-4923/17/1/52
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!